Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges BK Q1 2026 Earnings EPS Beats Estimates by 13 Revenue Data Withheld ARW Q1 2026 Earnings Stellar EPS Surpasses Estimates by Over 80 Pluri Inc Q1 2026 Earnings EPS Misses Estimates Amid Lack of Revenue Disclosure MDXH Q1 2026 Earnings EPS Miss and Negative Surprise Weigh on Shares JELDWEN Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions